![Sheldon Sloan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sheldon Sloan
Teknisk/Vetenskaplig/F&U Direktör på
SPYRE THERAPEUTICS, INC.
Profil
Sheldon Sloan is Chief Medical Officer at Spyre Therapeutics, Inc. since 2024.
Formerly, Chief Medical Officer at Abivax SA from 2023 to 2024.
Education includes graduate degree from the University of Pennsylvania, undergraduate degree from Illinois Urbana Champaign University of, and doctorate from Rush Medical College.
Aktiva positioner av Sheldon Sloan
| Företag | Position | Start |
|---|---|---|
| SPYRE THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-10-01 |
Tidigare kända positioner av Sheldon Sloan
| Företag | Position | Slut |
|---|---|---|
| ABIVAX | Teknisk/Vetenskaplig/F&U Direktör | 2024-07-15 |
Sheldon Sloans utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
45
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rush Medical College
 Rush Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
